ArticleCancer science2013
MDM2 is a useful prognostic biomarker for resectable gastric cancer.
Yang Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ArticleCancer science2013
Yang Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.